Collegium Pharmaceutical, Inc. Marketable Securities (Current)
Collegium Pharmaceutical, Inc. (COLL) had Marketable Securities (Current) of $0 as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Short-Term Investments
us-gaap:MarketableSecuritiesCurrent · last filed 2026-08-06
- 2026-06-30: Marketable Securities, Current $0.00.
- 2026-03-31: Marketable Securities, Current $153.10M.
- 2025-12-31: Marketable Securities, Current $155.43M.
- 2025-09-30: Marketable Securities, Current $135.77M.
| Period end | Marketable Securities, Current |
|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-06 |
| 2026-03-31 | $153.10M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $155.43M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $135.77M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $104.81M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $101.58M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $92.20M 10-K · filed 2026-02-26 |
| 2024-09-30 | $81.00M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $98.74M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $89.44M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $71.60M 10-K · filed 2025-02-27 |
| 2023-09-30 | $46.03M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $41.72M 10-Q · filed 2023-08-03 |
| 2022-12-31 | $0.00 10-Q · filed 2023-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |